Literature DB >> 3829859

The long-term outcome in Crohn's disease.

P H Harper, V W Fazio, I C Lavery, D G Jagelman, F L Weakley, R G Farmer, K A Easley.   

Abstract

The long-term outcome of Crohn's disease was reviewed in 139 patients who were treated at the Cleveland Clinic for a minimum of 15 years. At the time of diagnosis, 38 (27 percent), 39 (28 percent) and 62 (43 percent) patients had small-bowel, large-bowel, and ileocolic patterns of disease, respectively. The disease progressed with time and, eventually, 104 (75 percent) patients had ileocolic disease. One hundred twenty-two patients (88 percent) underwent at least one definitive operation for the disease. Forty-four (32 percent) patients had proctocolectomies and 65 (47 percent) have ileostomies. Associated manifestations of Crohn's disease occurred in a high proportion of patients; perianal disease in 78 (56 percent), intestinal fistulas in 45 (32 percent), extraintestinal disease in 49 (35 percent). Six patients died of causes directly related to the disease. Specific complications tend to occur at definite times in the course of the disease. Crohn's disease is not a benign condition. There is a relentless progression of the disease and a high incidence of complications when patients are followed over a long period.

Entities:  

Mesh:

Year:  1987        PMID: 3829859     DOI: 10.1007/bf02554332

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  18 in total

Review 1.  Managing Perianal Crohn’s Disease.

Authors:  Dawn M Wiese; David A Schwartz
Journal:  Curr Gastroenterol Rep       Date:  2012-04

2.  Drug treatments for maintaining remission in Crohn's disease. A lifetime cost-utility analysis.

Authors:  G Trallori; A Messori
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

3.  Intestinal stenosis and perforating complications in Crohn's disease.

Authors:  F Makowiec; E C Jehle; G Köveker; H D Becker; M Starlinger
Journal:  Int J Colorectal Dis       Date:  1993-12       Impact factor: 2.571

4.  Clinical course and long-term prognosis of Crohn's disease in Japan.

Authors:  M Okada; T Sakurai; T Yao; M Iida; N Okabe; K Maeda; T Matsui; T Fuchigami; K Yoshinaga; K Imamura
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

5.  Small bowel MRI enteroclysis or follow through: which is optimal?

Authors:  Ian C Lawrance; Christopher J Welman; Peter Shipman; Kevin Murray
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

6.  Correlation of MRI-determined small bowel Crohn's disease categories with medical response and surgical pathology.

Authors:  Ian Craig Lawrance; Christopher J Welman; Peter Shipman; Kevin Murray
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

7.  Risks of intestinal anastomoses in Crohn's disease.

Authors:  S Post; M Betzler; B von Ditfurth; G Schürmann; P Küppers; C Herfarth
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

8.  Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.

Authors:  Rona L Levy; Miranda A L van Tilburg; Shelby L Langer; Joan M Romano; Lynn S Walker; Lloyd A Mancl; Tasha B Murphy; Robyn L Claar; Shara I Feld; Dennis L Christie; Bisher Abdullah; Melissa M DuPen; Kimberly S Swanson; Melissa D Baker; Susan A Stoner; William E Whitehead
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

9.  Crohn's disease: risk of recurrence and reoperation in a defined population.

Authors:  S Shivananda; M L Hordijk; A S Pena; J F Mayberry
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

Review 10.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.